IXICO has secured one of its biggest contracts yet, worth $7m over seven years for clinical trial services. The award supports our investment thesis and financial forecasts, reflecting strong growth through the expansion into new indications, new markets and bigger contracts. IXICO is also well placed to capitalise on the burgeoning use of digital technologies in disease management. Using a DCF, we value IXICO at £10.7m or 63p/share.
02 Sep 2015
Clinical trial contract award raising the bar
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Clinical trial contract award raising the bar
IXICO has secured one of its biggest contracts yet, worth $7m over seven years for clinical trial services. The award supports our investment thesis and financial forecasts, reflecting strong growth through the expansion into new indications, new markets and bigger contracts. IXICO is also well placed to capitalise on the burgeoning use of digital technologies in disease management. Using a DCF, we value IXICO at £10.7m or 63p/share.